» Articles » PMID: 37641856

Findings of Intravenous Gadolinium Inner Ear Magnetic Resonance Imaging in Patients With Acute Low-Tone Sensorineural Hearing Loss

Overview
Date 2023 Aug 29
PMID 37641856
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Acute low-tone sensorineural hearing loss (ALHL) is thought to have a different etiology from that of idiopathic sudden sensorineural hearing loss. We hypothesized that endolymphatic hydrops (EH) in the inner ear organ contributes to ALHL, even in patients without vertigo. This study investigated the presence of EH in ALHL and compared the clinical characteristics of patients with or without EH.

Methods: We retrospectively reviewed 38 patients diagnosed with ALHL without vertigo from January 2017 to March 2022. EH was measured in all patients using inner ear magnetic resonance imaging (MRI). In addition, we selected patients who showed only mid- or high-frequency hearing loss and had available MRI data as a control group and compared the ALHL and control groups.

Results: After treatment, the pure-tone average at low frequencies significantly improved compared to the initial hearing (P<0.001). Hearing recovery was observed in 63.1% of patients; however, the recovery rate did not differ based on the treatment method. During the follow-up period, six patients (15.8%) progressed to Meniere's disease, and 18 (47.4%) experienced recurrence. In the ALHL group, the cochlear hydrops ratio on the affected side (0.34±0.09) was significantly higher than on the contralateral side (0.29±0.12) (P=0.005), and most patients showed hydrops in the apex area of the cochlea. Compared with the control group (0.25±0.15), the ALHL group showed a significantly higher cochlear hydrops ratio (P=0.043). The correlation analysis showed a tendency for hearing thresholds at low frequencies to increase as the hydrops ratio increased, albeit without statistical significance.

Conclusion: The cochlear hydrops ratio, especially in the apex area on the affected side, was significantly higher in patients with ALHL, suggesting that EH in the cochlea contributes to the pathogenesis of ALHL.

References
1.
Imamura S, Nozawa I, Imamura M, Murakami Y . Clinical observations on acute low-tone sensorineural hearing loss. Survey and analysis of 137 patients. Ann Otol Rhinol Laryngol. 1997; 106(9):746-50. DOI: 10.1177/000348949710600906. View

2.
Gurkov R, Pyyko I, Zou J, Kentala E . What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops. J Neurol. 2016; 263 Suppl 1:S71-81. PMC: 4833790. DOI: 10.1007/s00415-015-7930-1. View

3.
Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T . Visualization of endolymphatic hydrops in Ménière's disease with single-dose intravenous gadolinium-based contrast media using heavily T(2)-weighted 3D-FLAIR. Magn Reson Med Sci. 2010; 9(4):237-42. DOI: 10.2463/mrms.9.237. View

4.
Seo H, Chung J, Byun H, Lee S . Vestibular mapping assessment in idiopathic sudden sensorineural hearing loss. Ear Hear. 2021; 43(1):242-249. DOI: 10.1097/AUD.0000000000001129. View

5.
Shin S, Byun S, Park S, Kim E, Kim M, Lee H . Optimal First-Line Therapy for Acute Low-Tone Sensorineural Hearing Loss. J Audiol Otol. 2021; 25(4):209-216. PMC: 8524122. DOI: 10.7874/jao.2021.00269. View